Nasdaq
MBRX
Moleculin Biotech, Inc.
- Health Care
- Listed 2016
- 1 day
- −1.3%
- 1 month
- −83.4%
- 1 year
- −97.7%
$0.3850 · Mkt cap $7.50M
At the 6 Aug 2026 close
Nasdaq
Moleculin Biotech, Inc.
$0.3850 · Mkt cap $7.50M
At the 6 Aug 2026 close
Moleculin Biotech, Inc. trades under the ticker MBRX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2016. Its market capitalisation is $7.50M. The last closing price was $0.3850, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −97.7%, and −83.4% over the past month. Returns are price returns and exclude dividends.
This page exists because MBRX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.